Natalija Bogunovic

Natalija Bogunovic

Auto-generated profile, based on publicly available information

Natalija Bogunovic

Leiden University Medical Center , Leiden , Netherlands (The)

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2021 in European Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
KRKarlijn B. Rombouts
Karlijn B. Rombouts
TMTara A. R. van Merrienboer
Tara A. R. van Merrienboer
JKJohannes C. F. Ket
Johannes C. F. Ket
NBNatalija Bogunovic
Natalija Bogunovic
JVJolanda van der Velden
Jolanda van der Velden
KYKak Khee Yeung
Kak Khee Yeung
Background: Aortic aneurysms (AA) are pathological dilations of the aorta, associated with an overall mortality rate up to 90% in case of rupture. In addition to dilation, the aortic layers can separate by a tear within the layers, defined as aortic dissections (AD). Vascular smooth muscle cells (vSMC) are the predominant cell type within the aortic wall and dysregulation of vSMC functions contributes to AA and AD development and progression. However, since the exact underlying mechanism is poorly understood, finding potential therapeutic targets for AA and AD is challenging and surgery remains the only treatment option.Methods: In this review, we summarize current knowledge about vSMC functions within the aortic wall and give an overview of how vSMC functions are altered in AA and AD pathogenesis, organized per anatomical location (abdominal or thoracic aorta).Results: Important functions of vSMC in healthy or diseased conditions are apoptosis, phenotypic switch, extracellular matrix regeneration and degradation, proliferation and contractility. Stressors within the aortic wall, including inflammatory cell infiltration and (epi)genetic changes, modulate vSMC functions and cause disturbance of processes within vSMC, such as changes in TGF‐β signalling and regulatory RNA expression.Conclusion: This review underscores a central role of vSMC dysfunction in abdominal and thoracic AA and AD development and progression. Further research focused on vSMC dysfunction in the aortic wall is necessary to find potential targets for noninvasive AA and AD treatment options.

1 January 2017 in The American Journal of Human Genetics
Verified
Journal Article
Open access
TPTamara Paff
Tamara Paff
NLNiki T. Loges
Niki T. Loges
IAIsabella Aprea
Isabella Aprea
KWKaman Wu
Kaman Wu
ZBZeineb Bakey
Zeineb Bakey
DMDimitra Micha
Dimitra Micha
Defects in motile cilia and sperm flagella cause primary ciliary dyskinesia (PCD), characterized by chronic airway disease, infertility, and left-right body axis disturbance. Here we report maternally inherited and de novo mutations in PIH1D3 in four men affected with PCD. PIH1D3 is located on the X chromosome and is involved in the preassembly of both outer (ODA) and inner (IDA) dynein arms of cilia and sperm flagella. Loss-of-function mutations in PIH1D3 lead to absent ODAs and reduced to absent IDAs, causing ciliary and flagellar immotility. Further, PIH1D3 interacts and co-precipitates with cytoplasmic ODA/IDA assembly factors DNAAF2 and DNAAF4. This result has clinical and genetic counseling implications for genetically unsolved male case subjects with a classic PCD phenotype that lack additional phenotypes such as intellectual disability or retinitis pigmentosa.

2 May 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
NBNatalija Bogunovic
Natalija Bogunovic
JMJorn P. Meekel
Jorn P. Meekel
DMDimitra Micha
Dimitra Micha
JBJan D. Blankensteijn
Jan D. Blankensteijn
PHPeter L. Hordijk
Peter L. Hordijk
KYKak K. Yeung
Kak K. Yeung
Ruptured abdominal aortic aneurysms (AAA) are associated with overall mortality rates up to 90%. Despite extensive research, mechanisms leading to AAA formation and advancement are still poorly understood. Smooth muscle cells (SMC) are predominant in the aortic medial layer and maintain the wall structure. Apoptosis of SMC is a well-known phenomenon in the pathophysiology of AAA. However, remaining SMC function is less extensively studied. The aim of this study is to assess the in vitro contractility of human AAA and non-pathologic aortic SMC. Biopsies were perioperatively harvested from AAA patients (n = 21) and controls (n = 6) and clinical data were collected. Contractility was measured using Electric Cell-substrate Impedance Sensing (ECIS) upon ionomycin stimulation. Additionally, SMC of 23% (5 out of 21) of AAA patients showed impaired maximum contraction compared to controls. Also, SMC from patients who underwent open repair after earlier endovascular repair and SMC from current smokers showed decreased maximum contraction vs. controls (p = 0.050 and p = 0.030, respectively). Our application of ECIS can be used to study contractility in other vascular diseases. Finally, our study provides with first proof that impaired SMC contractility might play a role in AAA pathophysiology.

11 January 2017 in Human Mutation
Verified
Journal Article
Closed access
PDF file
KYKak K. Yeung
Kak K. Yeung
NBNatalija Bogunovic
Natalija Bogunovic
NKNiels Keekstra
Niels Keekstra
ABAdriaan A.M. Beunders
Adriaan A.M. Beunders
JPJorrit Pals
Jorrit Pals
BDBehrouz Zandieh Doulabi
Behrouz Zandieh Doulabi
Mutations in genes encoding proteins of the smooth muscle cell (SMC) contractile apparatus contribute to familial aortic aneurysms. To investigate the pathogenicity of these mutations, SMC are required. We demonstrate a novel method to generate SMC-like cells from human dermal fibroblasts by transdifferentiation to study the effect of variants in genes encoding proteins of the SMC contractile apparatus (ACTA2 and MYH11) in patients with aortic aneurysms. Dermal fibroblasts from seven healthy donors and cells from seven patients with MYH11 or ACTA2 variants were transdifferentiated into SMC-like cells within a 2-week duration using 5 ng/ml TGFβ1 on a scaffold containing collagen and elastin. The induced SMC were comparable to primary human aortic SMC in mRNA expression of SMC markers which was confirmed on the protein level by immunofluorescence quantification analysis and Western blotting. In patients with MYH11 or ACTA2 variants, the effect of intronic variants on splicing was demonstrated on the mRNA level in the induced SMC, allowing classification into pathogenic or nonpathogenic variants. In conclusion, direct conversion of human dermal fibroblasts into SMC-like cells is a highly efficient method to investigate the pathogenicity of variants in proteins of the SMC contractile apparatus.

1 January 2018 in Cardiovascular Pathology
Verified
Journal Article
Open access
MGMenno Evert Groeneveld
Menno Evert Groeneveld
NBNatalija Bogunovic
Natalija Bogunovic
RMRené John Philip Musters
René John Philip Musters
GTGeert Jan Tangelder
Geert Jan Tangelder
GPGerard Pals
Gerard Pals
KYKak Khee Yeung
Kak Khee Yeung
Background: Marian syndrome (MIS), a congenital connective tissue disorder leading to aortic aneurysm development, is caused by fibrillin-1 (FBN1) gene mutations. Transforming growth factor beta (TGF-beta) might play a role in the pathogenesis. It is still a matter of discussion if and how TGF-beta, up-regulates the intracellular downstream pathway, although TGF-beta receptor 3 (TGFBR3 or Betaglycan) is thought to be involved. We aimed to elucidate the role of TGFBR3 protein in TGF-beta signaling in Marfan patients. Methods: Dermal fibroblasts of MIS patients with haploinsufficient (HI; n=9) or dominant negative (DN; n=4) FBN1 gene mutations, leading to insufficient or malfunctioning fibrillin-1, respectively, were used. Control cells (n = 10) were from healthy volunteers. We quantified TGFBR3 protein expression by immunofluorescence microscopy and gene expression of FBN1, TGFB1, its receptors, and downstream transcriptional target genes by quantitative polymerase chain reaction. Results: Betaglycan protein expression in FBN1 mutants pooled was higher than in controls (P=.004) and in DN higher than in HI (P=.015). In DN, significantly higher mRNA expression of FBN1 (P=.014), SMAD7 (P=.019), FISP47 (P=.023), and SERPINE1 (P=.008), but a lower FISPA5 expression (P=.029), was observed than in HI. A pattern of higher expression was noted for TGFB1 (P=.059), FN1 (P=.089), and COL1A1 (P=.089) in DN as compared to HI. TGFBR3 protein expression in cells, both presence in the encloplasmic reticulum and amount of yes ides per cell, correlated positively with TGEB1 mRNA expression (Rs=0.60, P=.017; Rs=0.55, P=.029; respectively). TGFBR3 gene expression did not differ between groups. Conclusion: We demonstrated that activation of TGF-beta signaling is higher in patients with a DN than an HI FBN1 gene mutation. Also, TGFBR3 protein expression is increased in the DN group and correlates positively with TGFB1 expression in groups pooled. We suggest that TGFBR3 protein expression is involved in up-regulated TGF-beta signaling in MFS patients with a DN FBN1 gene mutation. (C) 2017 Elsevier Inc. All rights reserved.

25 May 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JMJorn P. Meekel
Jorn P. Meekel
MGMenno E. Groeneveld
Menno E. Groeneveld
NBNatalija Bogunovic
Natalija Bogunovic
NKNiels Keekstra
Niels Keekstra
RMRené J. P. Musters
René J. P. Musters
KYKak K. Yeung
Kak K. Yeung
The pathophysiology of aortic aneurysms (AA) is far from being understood. One reason for this lack of understanding is basic research being constrained to fixated cells or isolated cell cultures, by which cell-to-cell and cell-to-matrix communications are missed. We present a new, in vitro method for extended preservation of aortic wall sections to study pathophysiological processes. Intraoperatively harvested, live aortic specimens were cut into 150 μm sections and cultured. Viability was quantified up to 92 days using immunofluorescence. Cell types were characterized using immunostaining. After 14 days, individual cells of enzymatically digested tissues were examined for cell type and viability. Analysis of AA sections (N = 8) showed a viability of 40% at 7 days and smooth muscle cells, leukocytes, and macrophages were observed. Protocol optimization (N = 4) showed higher stable viability at day 62 and proliferation of new cells at day 92. Digested tissues showed different cell types and a viability up to 75% at day 14. Aortic tissue viability can be preserved until at least 62 days after harvesting. Cultured tissues can be digested into viable single cells for additional techniques. Present protocol provides an appropriate ex vivo setting to discover and study pathways and mechanisms in cultured human aneurysmal aortic tissue.